Login
Join
FOLLOW:
Subscribe Free
Magazine
eNewsletter
Checkout
Menu
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
More
Magazine
News
Manufacturing
Packaging
Development
Compliance
Top 20
Directory
Solution Center
Events
Current / Back Issue
Features
Editorial
Columns
Digital Edition
eNewsletter Archive
Our Team
Editorial Guidelines
Subscribe Now
Advertise Now
Top Features
Big Pharma Ramps up Expansion to Emerging Markets
How to Utilize FSPs for Better Outcomes
Breaking Barriers: Strategic Use of FSP Models to Expand Trials into Non-Footprint Countries
Exploring Oligonucleotide Drugs: An Overview of Pharmacokinetic & Bioanalytical Strategies
Indian Pharmaceutical Industry at a Crossroads
Breaking News
Online Exclusives
Industry News
Collaborations & Alliances
Promotions & Moves
Trials & Filings
Financial Reports
Bio News & Views
Custom Sourcing News
Packaging & Tracking
CRO News
Live From Shows
Top News
Piramal Pharma Revenue Increases 12% YoY in Q1
Cellectis’ UCART22 Granted ODD and RPDD Status by FDA
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility
Pace Life Sciences Completes Successful FDA Inspection of Operations in Oakdale, MN
Emmes, Miimansa AI Partner on Generative AI in Clinical Research
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility
Pace Life Sciences Completes Successful FDA Inspection of Operations in Oakdale, MN
Almac Completes FDA Inspection at Charnwood, UK Facilities
Capra Biosciences Receives $7.5M Project Agreement
RxSource to Relocate to Larger Facility in West Deptford, NJ
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Contract Pharma Talks with Tom Handel of Kindeva Drug Delivery
Good as Gold: Douglas CDMO
Antares Vision Group Launches Supply Chain Visibility Solution
"3 Key Trends" with Stacey Treichler
Pharma Matters Podcast: Contract Pharma Talks with Tom Wilson of Pfizer CentreOne
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Cellectis’ UCART22 Granted ODD and RPDD Status by FDA
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility
Pace Life Sciences Completes Successful FDA Inspection of Operations in Oakdale, MN
Emmes, Miimansa AI Partner on Generative AI in Clinical Research
Trends Impacting Clinical Trials Today
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Pace Life Sciences Completes Successful FDA Inspection of Operations in Oakdale, MN
Almac Completes FDA Inspection at Charnwood, UK Facilities
Nordic Bioproducts Receives EXCiPACT Certification for MCC Production at Lappeenranta Facility
Upperton Pharma Gains MHRA Approval at Nottingham Facility
Quality Management Systems: The Future of Quality Oversight
Companies
Categories
Corporate Capabilities
Add New Company
Contract Service Directory Companies
LOTTE BIOLOGICS
UBI Pharma Inc.
AMERIPHARMA
Abzena
INCOG BioPharma Services
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Jobs
Contract Service Directory Companies
LOTTE BIOLOGICS
UBI Pharma Inc.
AMERIPHARMA
Abzena
INCOG BioPharma Services
Webinars
Live From Shows
Magazine
Current / Back Issue
Features
Editorial
Columns
Editorial Guidelines
Subscribe Now
Advertise Now
Enewsletter Archive
Digital Edition
Directory
Companies
Categories
Corporate Capabilities
Add Your Company
Manufacturing
APIs
Aseptic Processing
Cleaning Validation
Clinical Trial Materials
Cytotoxics and High Potency Manufacturing
Equipment
Excipients
Extractables and Leachables
Facilities
Fill/Finish
Lyophilization
Parenterals
Process Development
Process Validation
Risk Management
Scale-up/ Technology Transfer
Solid Dosage/ Creams/ Ointments
cGMP Manufacture
Packaging
Capsules
Cold Chain Management
Injectables
Logistics
Serialization
Solid Dosage / Semi-solids
Supply Chain
Vials
Development
Analytical Services
Bioanalytical Services
Bioassay Developement
Biologics, Proteins, Vaccines
Biosimilars
Chemistry
Clinical Trials
Drug Delivery
Drug Development
Drug Discovery
Formulation Development
Information Technology
Laboratory Testing
Methods Development
Microbiology
Preclinical Outsourcing
R&D
Toxicology
Compliance
Filtration & Purification
GMPs/GCPs
Inspections
QA/QC
Regulatory Affairs
Validation
Top 20 Pharma & BioPharma
Contract Pharma Direct
Breaking News
Online Exclusives
Slideshows
Experts Opinions
Surveys
Outsourcing Survey
Salary Survey
Glossary
Videos
White Papers
Podcasts
Infographics
Microsites
Companies
News Releases
Posters
Brochures
Services
Videos
Case Study
White Papers
Contract Pharma Conference
Contract Pharma Conference
Speakers
Exhibitors
Conference Sessions
eBook
Webinars
Events
Industry Events
Live from Show Events
Webinars
Classifieds / Job Bank
Classifieds
Job Bank
About Us
About Us
Contact Us
Advertise With Us
Privacy Policy
Terms of Use
Collaborations & Alliances
All News
Bio News
Breaking News
Collaborations & Alliances
CRO News
Custom Sourcing News
Financial Reports
Industry News
Packaging & Tracking
Pharma Matters Q&A
Promotions & Moves
Reader Showcase
Trials & Filings
VideoBites
Breaking News
|
Collaborations & Alliances
Catalyst Grants Kye Exclusive Canadian Commercial Rights to AGAMREE
Catalyst will supply the product to Kye, which will assume full responsibility for obtaining regulatory approval for the novel corticosteroid.
07.25.24
Analytical Services
|
Breaking News
|
Collaborations & Alliances
Neuraxpharm to Utilize Veeva Quality Applications
Will drive seamless collaboration across Neuraxpharm’s network of over 100 CDMOs.
07.25.24
Breaking News
|
Collaborations & Alliances
|
Drug Development
|
Industry News
De Motu Cordis Expands DPI Partnership with Catalent
Announces plans for the next stage of development for DMC-IH1, an inhaled epinephrine drug device combination product.
07.24.24
Analytical Services
|
Breaking News
|
Collaborations & Alliances
IDT Bolsters CRISPR Portfolio with SeQure Dx Licensing Deal
Agreement enables IDT to support cell and gene therapy developers through all phases of their CRISPR-based therapeutic programs.
07.24.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
Touchlight, GSK Enter License Agreement
Grants GSK non-exclusive rights to use Touchlight’s proprietary enzymatic dbDNA technology.
07.23.24
Breaking News
|
Collaborations & Alliances
EMS and Azer Integrate to Become Biolyst Scientific
The combined company strives to be a significant partner to innovative clinical and research laboratories.
07.22.24
Breaking News
|
Collaborations & Alliances
Gilead Sciences Extends RADIAN Partnership to Combat the HIV Epidemic
Expands its efforts to support initiatives to help meet the needs of vulnerable key populations across Eastern Europe and Central Asia.
07.22.24
Breaking News
|
Collaborations & Alliances
NorthStar, BWXT Sign Master Services Agreement Supporting Actinium-225 Production
Actinium-225 is a critical medical isotope used to kill cancer cells while minimizing the impact to healthy tissues.
07.22.24
Bio News
|
Breaking News
|
Clinical Trial Materials
|
Collaborations & Alliances
|
Industry News
Andelyn Biosciences, UMass Partner on Cockayne Syndrome
The cell and gene therapy CDMO was chosen by UMass Chan Medical School to manufacture clinical grade AAV9-CSA vector to treat Cockayne syndrome.
07.18.24
Bio News
|
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
|
Industry News
Univercells Technologies & UPENN Expand Gene Therapy Partnership
Will evaluate certain bioreactors for scalable gene therapy production.
07.18.24
Breaking News
|
Collaborations & Alliances
Brainomix, Boehringer Ingelheim Partner on Fibrosing Lung Disease
Will utilize AI imaging analysis using Brainomix 360 e-Lung on routine CT scans to accelerate the diagnosis and improve access to treatment.
07.18.24
Breaking News
|
Collaborations & Alliances
|
Drug Development
Full-Life Technologies, SK Biopharma Enter $571.5M License Agreement for FL-091
FL-091 is a small-molecule radioligand vector designed to deliver targeted radiation therapy to cancer cells by binding specifically to NTSR1.
07.17.24
Biologics, Proteins, Vaccines
|
Breaking News
|
Collaborations & Alliances
SPI Pharma, Inimmune Partner to Develop & Commercialize Adjuvant Systems
Collaboration aims to provide reliable supply and open access to advanced adjuvant systems.
07.16.24
Breaking News
|
Collaborations & Alliances
|
Drug Development
Boehringer Ingelheim India Pledges Grant to Foster Healthcare Innovation in Dementia Care
Enters collaboration with the Startup Incubation and Innovation Centre.
07.16.24
Breaking News
|
Collaborations & Alliances
|
Drug Development
Tiba Biotech, BARDA Partner to Develop Therapeutics Against Influenza
Tiba Biotech's initial focus will be on developing a prototype RNAi-based therapeutic for H1N1 influenza.
07.15.24
Breaking News
|
Collaborations & Alliances
XyloCor Therapeutics, SmartWise Enter License Agreement for Use of Extroducer
XyloCor to deploy the Extroducer to support catheter-based endocardial delivery of its lead gene therapy candidate XC001.
07.10.24
Breaking News
|
Collaborations & Alliances
Nusano, PharmaLogic Enter Supply Agreement to Provide Critical Radioisotopes
Will increase access to radioisotope supplies provided by Nusano for use in products produced in PharmaLogic's network of facilities.
07.10.24
Breaking News
|
Collaborations & Alliances
|
Drug Discovery
Evotec, Pfizer Enter Multi-Year Master Research Collaboration
Will collaborate to conduct discovery research for metabolic and infectious diseases.
07.10.24
Breaking News
|
Clinical Trials
|
Collaborations & Alliances
Prelude Therapeutics, Merck Enter Clinical Collaboration
Will evaluate PRT3789 in combination with KEYTRUDA (pembrolizumab) in patients with SMARCA4-mutated cancers.
07.09.24
Breaking News
|
Collaborations & Alliances
Aptamer Group Partners with AstraZeneca for Targeted Delivery of siRNA
New collaboration will evaluate Aptamer’s fibrotic liver delivery vehicles with siRNA.
07.08.24
Breaking News
Piramal Pharma Revenue Increases 12% YoY in Q1
Cellectis’ UCART22 Granted ODD and RPDD Status by FDA
BeiGene Opens Flagship U.S. Biologics Manufacturing and Clinical R&D Facility
Pace Life Sciences Completes Successful FDA Inspection of Operations in Oakdale, MN
Emmes, Miimansa AI Partner on Generative AI in Clinical Research
View Breaking News >
CURRENT ISSUE
July/August 2024
Big Pharma Ramps up Expansion to Emerging Markets
How to Utilize FSPs for Better Outcomes
View More >